Gufic Biosciences Limited
Gufic Biosciences Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: GUFICBIO and BSE: 509079 (ISIN INE742B01025).
It has a market capitalisation of ₹4,056 crore, a last close of ₹404.45 on 2026-10-19, a one-year return of 15.0%.
Valuation: a price-to-earnings ratio of 55.16x, a price-to-book ratio of 6.11x, a dividend yield of 0.0%.
Profitability: return on equity of 10.0%, return on capital employed of 15.2%, an operating margin of 16.9%.
Growth: sales growth of 10.8% a year over three years, net profit growth of -7.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.58x, promoter holding of 72.5%.
| Metric | Value |
|---|---|
| Market capitalisation | 4,056 |
| Last close | ₹404.45 |
| P/E (TTM) | 55.16x |
| P/B | 6.11x |
| Dividend yield | 0.0% |
| ROE (FY) | 10.0% |
| ROCE (FY) | 15.2% |
| Operating margin (TTM) | 16.9% |
| Sales growth, 3-year CAGR | 10.8% |
| Profit growth, 3-year CAGR | -7.5% |
| Debt / equity | 0.58x |
| Promoter holding | 72.5% |
| 1-year return | 15.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means